Another study evaluated the relationship between presurgical fasting glucagon, active ghrelin, GLP-1, and glucose-dependent insulinotropic polypeptide (GIP) and maximal total body weight loss (WLmax) achieved, 5 years after RYGB, in a cohort that included patients with and without T2D. The gene discussed is GCG; the disease is type 2 diabetes mellitus.